What is Ocular Therapeutix's interest expense?

Ocular Therapeutix (OCUL) reported interest expense of $2.78M in Q1 2026.

How has Ocular Therapeutix's interest expense changed year-over-year?

Ocular Therapeutix's interest expense decreased by 6.9% year-over-year, from $2.98M to $2.78M.

What is the long-term trend for Ocular Therapeutix's interest expense?

Over 4 years (2021 to 2025), Ocular Therapeutix's interest expense has grown at a 15.4% compound annual growth rate (CAGR), from $6.67M to $11.83M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ocular Therapeutix OCUL Interest Expense

Interest Expense at other companies

Regeneron PharmaceuticalsREGN

$12.9M+48.3%

Bausch + LombBLCO

$97M+3.2%

HRO

HarrowHROW

$5.5M-16.1%

Tarsus Pharmaceuticals, Inc.TARS

$2.13M-3.8%

Arcutis Biotherapeutics, Inc.ARQT

$4.37M+46.5%

LQD

Liquidia CorporationLQDA

$6.49M+39.1%

Segments

By segment

See full

Single Reportable$2.78M-6.9%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's interest expense?: Ocular Therapeutix (OCUL) reported interest expense of $2.78M in Q1 2026.
How has Ocular Therapeutix's interest expense changed year-over-year?: Ocular Therapeutix's interest expense decreased by 6.9% year-over-year, from $2.98M to $2.78M.
What is the long-term trend for Ocular Therapeutix's interest expense?: Over 4 years (2021 to 2025), Ocular Therapeutix's interest expense has grown at a 15.4% compound annual growth rate (CAGR), from $6.67M to $11.83M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.